Bajaj Healthcare

48
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
344.10
7.95 (2.37%)
BSENSE

Sep 23, 09:24 AM

BSE+NSE Vol: 78.07 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 27.17% vs 8.08% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -20.32% vs -5.98% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -50.36% vs 399.64% in Mar 2025

Compare Profit and Loss Results of Bajaj Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
611.00
342.00
269.00
78.65%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
611.00
342.00
269.00
78.65%
Expenditure (Ex Depriciation)
Stock Adjustments
10.00
9.00
1.00
11.11%
Raw Materials Consumed
306.00
120.00
186.00
155.00%
Power & Fuel Cost
31.00
12.00
19.00
158.33%
Employee Cost
62.00
93.00
-31.00
-33.33%
Operating Expenses
57.00
29.00
28.00
96.55%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
19.00
-14.00
-73.68%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
10.00
17.00
-7.00
-41.18%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
506.00
341.00
165.00
48.39%
Operating Profit (PBDIT) excl Other Income
104.00
0.00
104.00
0%
Other Income
7.00
9.00
-2.00
-22.22%
Operating Profit (PBDIT)
111.00
9.00
102.00
1,133.33%
Interest
22.00
10.00
12.00
120.00%
Profit before Depriciation and Tax
89.00
0.00
89.00
0%
Depreciation
27.00
10.00
17.00
170.00%
Profit Before Taxation & Exceptional Items
62.00
-11.00
73.00
663.64%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
28.00
-13.00
41.00
315.38%
Provision for Tax
7.00
0.00
7.00
0%
Profit After Tax
21.00
-14.00
35.00
250.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
304.00
174.00
130.00
74.71%
Profit Available for appropriations
325.00
160.00
165.00
103.12%
Appropriations
325.00
160.00
165.00
103.12%
Equity Dividend (%)
30%
50%
-20.00
Earnings Per Share
4.98
-1.54
6.52
423.38%
Profit And Loss - Net Sales
Net Sales 611.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.61% vs 14.61% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.82 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.17% vs 8.08% in Mar 2025

Profit And Loss - Interest
Interest 22.23 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -20.32% vs -5.98% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 21.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -50.36% vs 399.64% in Mar 2025